Children with diabetes at higher risk for developing eating disorders, report says
NEW YORK Children with diabetes face an increased risk of having eating disorders, and researchers at Harvard University and Emory University want to know if how they are taught to control their eating habits has something to do with it.
Over the next three years, the researchers will study 90 children between the ages of 10 and 17 who have received new diabetes diagnoses or who have recently started using an insulin pump, analyzing their eating and weight, their attitudes about eating and weight, their treatment, psychological adjustment and blood sugar patterns.
The children and their parents will be given computer questionnaires to track their status.
The researchers have said the findings could influence the way diabetes is treated in children and adolescents.
FDA approves Galderma’s Epiduo Gel treatment for acne
ROCKVILLE, Md. The Food and Drug Administration has approved a new acne treatment by Galderma Laboratories, the agency announced Wednesday.
The treatment, Epiduo Gel, is known generically as adapalene and benzoyl peroxide and is used to treat acne vulgaris in patients aged 12 and older.
FDA records indicate the agency approved it Monday.
Galderma, based in Lausanne, Switzerland, had not made a statement about the approval at midday Wednesday.
Wyeth announces lay-offs at operations in Puerto Rico
SAN JUAN, Puerto Rico More than 200 Wyeth Pharmaceuticals employees in Puerto Rico will lose their jobs between the end of the year and February, according to the Associated Press.
The drug maker said it would lay off 276 workers as part of a restructuring plan and drop in demand. The company employs about 3,000 people in the territory.
A spokeswoman for the company said the availability of generics reduced demand for the anti-anxiety drug Effexor (venlafaxine hydrochloride) and the acid reflux disease drug Protonix (pantoprazole sodium).